CJC-1295 / Ipamorelin

10mg · Combined Blend

A combined GHRH analog + selective ghrelin-receptor agonist blend — the most common pairing in growth-hormone-axis research.

Form: Lyophilized

Storage: -20°C

$85 CAD

Research use only · lyophilized

Add to Cart

Research use only. You must be 18+ and a qualified researcher. Canada shipping only.

About this Blend

This blend pairs CJC-1295 (a GHRH analog) with Ipamorelin (a selective growth hormone secretagogue acting at the GHS-R1a receptor). The two act on separate receptor systems of the same axis, and the combination is widely used in preclinical work studying amplified, pulsatile GH release.

Proposed Mechanism

CJC-1295 stimulates the GHRH receptor on somatotrophs while Ipamorelin agonizes the ghrelin receptor — literature describes the dual pathway as synergistic in GH-release study models, with Ipamorelin noted for its selectivity (minimal reported effect on cortisol or prolactin in preclinical assays).

Specifications

Strength: 10mg (combined) per vial
Components: CJC-1295 + Ipamorelin
Form: Lyophilized white powder
Reconstitution: Bacteriostatic water (sold separately)
Storage: Store lyophilized at -20°C. Reconstituted: 2-8°C, use within 30 days.

Research Disclaimer

This compound is supplied for in vitro research and laboratory use only. It is not a drug, food, cosmetic, or dietary supplement. It is not intended to diagnose, treat, cure, or prevent any disease, and is not for human or animal consumption.